AIDS Marketplace
U.S. Market For AIDS Therapies $1 Billion And Growing
Published in Gene Therapy Weekly, September 28th, 1998
And as more U.S. patients buy more of the therapies - and thus live longer to buy even more - the market will keep growing for at least the rest of the decade, according to a new report by Datamonitor, a New York-based independent strategic management consultancy specializing in the analysis of global healthcare companies and their markets.
"The cost of maintaining patients using combination therapies will therefore increase as more people need the therapies longer," said Datamonitor analyst Patrick Taaffee. "Resistance to drugs is...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (1998-09-28)
More Articles from Gene Therapy Weekly
- Hematopoietic Gene Transfer
Ex Vivo Expansion Diminishes Long-Term Repopulating Ability of Stem Cells - Cancer Gene Therapy
Retinoblastoma Gene Therapy Inhibits Tumor Growth In Vivo - Suicide Gene Therapy
Successful VDEPT for Cancer Uses E. coli Nitroreductase and CB1954 - Targeted Chemotherapy
In Situ Chemotherapy with Genetically Modified Cells Holds Promise - AIDS Vaccines
Whether Live Vaccine Saves or Kills Up To Host Factors - Cell Biology
Elusive Chromosomal "Ignition" Identified - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
